Strategic leadership Recent leadership change with Tom Orr as CEO and President signals a potential shift in strategic direction, prioritizing growth, efficiency, and new business development opportunities. Engage to align Seaway’s expansion plans with your value propositions and leverage their refreshed leadership focus for joint initiatives.

Medical device focus Strong emphasis on medical, aerospace, military, and diagnostic medical markets, including EMI/RFI shielding capabilities. Target medical device and healthcare OEMs that require precision injection molding, low to mid-volume runs, and EMI/RFI shielding integration to pursue repeat business and value-added assembly opportunities.

Global footprint Five manufacturing locations across Florida, California, and Minnesota enable regional service capabilities and specialized product lines. Propose localized supply partnerships, nearshoring options, and flexible capacity planning to accommodate customer location preferences and faster time-to-market.

End-to-end capabilities Full service contract manufacturer with plastic injection molding, LSR, and assembly, plus mold making and rapid prototyping. Upsell service bundles for customers seeking turnkey solutions, EMI/RFI shielding integration, and rapid iterations for product development pipelines.

Growth through acquisitions Past momentum includes strategic acquisitions and PE-backed growth. Position Seaway as a potential partner for manufacturing consolidation or capacity expansion in target regions or adjacent markets, offering integration expertise, scalable processes, and risk-managed transitions.